AI Built for Pharma: Why Out-of-the-Box Beats Build-From-Scratch

“AI Built for Pharma: Why Out-of-the-Box Beats Build-from-Scratch” brings together top Pharma AI Council leaders to reveal why purpose-built AI solutions are overtaking homegrown systems. Hear firsthand from those who have tried both and why they’d never build from scratch again.

Register Free: https://www.pharmexec.com/pe_w/ai-built

Event Overview:

In today’s push to modernize commercial operations, life sciences leaders face a critical decision: build AI solutions in-house or adopt out-of-the-box platforms tailored for pharma. This panel, hosted by Pharmaceutical Executive and powered by ACTO, brings together senior members of the Pharma AI Council to dissect the real costs, risks, and delays that often come with custom-built approaches. Learn why more organizations are moving away from consultant-heavy builds and toward specialized, ready-to-deploy AI tools that offer seamless integration with systems like Veeva and Salesforce, ensuring compliance, and delivering faster time-to-value. If you’re navigating AI adoption in commercial ops, IT, CL&D, or innovation, this discussion offers data-backed insights and field-tested strategies to avoid costly missteps and to deploy AI that actually moves the needle.

Key Learning Objectives

• Understand the true costs of building AI in-house vs buying
• Learn why pharma teams are choosing out-of-the-box AI solutions
• Explore how built-for-pharma AI accelerates compliance and value

Who Should Attend

• Directors, vice presidents, and heads of commercial operations, IT, innovation, and CL&D
• Those in AI innovation roles
• Those responsible for digital transformation, commercial enablement, AI strategy, training, compliance, and technology implementation across field teams
• Individuals evaluating or deploying AI solutions to enhance commercial effectiveness and drive measurable business impact
• Those part of pharmaceutical, biotechnology, and medical device companies in the US, Canada, and Europe

Speakers

Kishan Kumar
Executive Director of Marketing,
Malignant Hematology
Novartis

Sarah Barrett
Associate Director, Medical Affairs
Training
Alnylam Pharmaceuticals

Bryce Emery King
Founder and Chief YAP Officer
BioYap

Register Free: https://www.pharmexec.com/pe_w/ai-built